Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cemindo Gemilang Tbk. (CMNT) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Cemindo Gemilang Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Cemindo Gemilang Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Cemindo Gemilang Tbk. trades at Rp790 (market cap 13.44T, 22.46M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Cemindo Gemilang Tbk. is far larger — about 80.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Cemindo Gemilang Tbk. is more actively traded (22.46M versus 71K). Which is the better fit depends on your goals.

CMNTOBAT
Market Cap
13.44T167.37B
Volume
22.46M71K
Lot
224.6K710
Turnover
17.62B17.51M
Average Price
784.39246.63
Value
17.62B17.51M
Indicative Equilibrium Price
790246
Indicative Equilibrium Volume
661

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CMNT
View details
OBAT
View details

About Cemindo Gemilang Tbk.

PT Cemindo Gemilang Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 9 of Humberg Lie, S.H., S.E., M.Kn, dated July 4, 2011.

Read more on CMNT

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT